Beam Therapeutics BEAM Income Statement (2019-2026)

NASDAQ BEAM
$29.83 +0.37 (+1.26%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Beam Therapeutics Quarterly Income Statement

Periods 30 quarters
Latest Jun 2026

Beam Therapeutics reported revenue of $0.49M and net income of -$123.80M for the quarter ended Jun 2026, down 94.2% year over year. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
67.73M68.39M69.75M70.31M70.46M71.28M74.44M77.95M79.38M81.63M82.28M82.39M82.56M83.63M100.56M100.76M101.36M101.75M102.74M103.26M
Revenue & cost
Revenue
0.76M51.07M8.43M16.65M15.80M20.04M24.21M20.12M17.19M316.19M7.41M11.77M14.27M30.07M7.47M8.47M9.70M114.11M31.74M0.49M
Operating items
Research & DevelopmentR&D
54.62M96.78M65.41M74.56M85.29M86.34M99.65M97.61M100.05M140.08M84.82M87.04M94.26M101.44M98.82M101.76M109.77M99.28M104.52M95.10M
Selling, General & AdministrativeSG&A
15.77M17.77M19.25M24.06M21.82M22.68M23.49M24.66M25.41M43.26M26.72M29.63M26.52M28.66M27.94M26.86M26.74M32.28M34.43M31.95M
Other Operating ExpensesOther Opex
Operating ExpensesOpex
70.40M114.55M84.66M98.62M107.10M109.02M123.14M122.26M125.46M183.33M111.54M116.67M120.77M130.10M126.76M128.62M136.51M131.55M138.95M127.04M
Operating IncomeOp. Inc
-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M-126.55M
EBIT
-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M-126.55M
Non-operating items
Non Operating Investment Income
-4.89M-4.27M-7.68M-4.12M10.43M21.58M-12.80M6.15M-11.22M-0.72M-3.35M-7.59M-2.06M-1.09M-2.08M4.42M4.94M-3.33M0.02M0.34M
Interest & Investment IncomeInt & Inv Inc
0.01M0.05M0.64M2.06M4.98M7.61M9.96M11.95M12.70M12.06M11.85M14.19M12.13M10.93M9.86M12.33M10.90M10.64M9.87M7.49M
Other Non Operating IncomeOther Non Op Inc.
35.80M7.40M13.60M12.20M-4.90M3.00M5.60M-0.90M4.70M-1.90M-2.90M5.50M-0.20M-0.13M3.20M1.30M-2.76M9.52M2.50M-4.20M
Non Operating IncomeNon Op. Inc.
41.52M-1.22M7.01M10.02M9.64M51.64M2.47M19.37M12.18M11.30M5.46M13.88M9.84M9.68M10.96M18.01M14.08M261.74M12.90M3.88M
Net income details
EBT
-28.12M-64.71M-75.58M-79.91M-81.67M-37.35M-88.97M-82.78M-96.09M144.16M-92.28M-91.01M-96.67M-90.35M-109.42M-102.29M-112.73M244.30M-97.35M-119.07M
Tax ProvisionsTaxes
2.41M1.00M1.40M0.04M-16.80M
Profit After TaxPAT
-28.13M-64.75M-69.21M-71.95M-110.06M-36.10M-96.46M-82.78M-96.10M142.80M-98.67M-91.05M-96.67M-90.35M-108.33M-102.29M-112.73M244.30M-94.32M-123.80M
Equity Income
-25.50M
Income from Continuing OperationsIncome (Continuing)
-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-82.78M-96.09M142.76M-92.28M-91.05M-96.67M-90.35M-109.42M-102.29M-112.73M261.10M-97.35M-119.07M
Consolidated Net IncomeConsol Net Inc.
-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-82.78M-96.09M142.76M-92.28M-91.05M-96.67M-90.35M-109.42M-102.29M-112.73M261.10M-97.35M-119.07M
Income towards Parent CompanyParent Net Inc
-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-82.78M-96.09M142.76M-92.28M-91.05M-96.67M-90.35M-109.42M-102.29M-112.73M261.10M-97.35M-119.07M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-28.12M-64.71M-69.21M-71.95M-109.58M-38.35M-96.46M-82.78M-96.09M142.80M-98.67M-91.05M-96.67M-90.35M-108.33M-102.14M-112.73M244.30M-94.32M-122.68M
Additional items
EPS (Basic)
-0.42-1.01-1.01-1.02-1.56-0.55-1.33-1.08-1.221.85-1.21-1.11-1.17-1.10-1.23-1.00-1.102.47-0.91-1.18
EPS (Diluted)
-0.42-1.01-1.01-1.02-1.56-0.55-1.33-1.08-1.221.85-1.21-1.11-1.17-1.10-1.23-1.00-1.102.47-0.91-1.18
Shares Outstanding
66.38M64.23M68.70M70.21M70.34M70.02M72.27M76.34M79.02M77.15M81.70M82.31M82.41M82.31M87.98M102.00M102.57M98.91M103.26M104.33M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
66.38M64.23M68.70M70.21M70.34M70.02M72.27M76.34M79.02M77.15M81.70M82.31M82.41M82.31M87.98M102.00M102.57M98.91M103.26M104.33M
EBITDA
-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M-17.45M-107.22M-126.55M
Tax Rate
-2.95-2.680.97-0.04-6.88